Depomed appoints new CMO
This article was originally published in Scrip
Executive Summary
Newark, California-based Depomed, a specialty pharmaceutical company that commercializes products for pain and neurology related disorders, has named Dr Srinivas G Rao chief medical officer and senior vice-president. Dr Rao, the founder and CEO of Kyalin Biosciences, a privately held biotechnology company acquired by Retrophin in 2013, was most recently executive vice-president and head of neuroscience at Retrophin.